|
|
|
BMY Dividend History & Description — Bristol Myers Squibb Co.
Bristol-Myers Squibb is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products on a global basis. Co.'s pharmaceutical products include chemically-synthesized or small molecule drugs, products produced from biological processes, called biologics and chimeric antigen receptor T-cell therapies. Co.'s primary product includes Eliquis® - Eliquis (apixaban), which is an oral Factor Xa inhibitor indicated for the reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation and for the treatment of DVT/PE and reduction in risk of recurrence following initial therapy. Preferred: BMYMP When considering the Bristol Myers Squibb Co. stock dividend history, we have taken known splits into account, such that the BMY dividend history is presented on a split-adjusted ("apples to apples") basis. Bristol Myers Squibb Co. dividend history is presented both in graphical/chart form, and as a BMY dividend history data table along the right-hand column.
|
BMY Stock Dividend HistoryThe BMY dividend history graphic shown above is presented after taking into consideration any known stock split occurrences, in order to present the most directly comparable BMY historical dividend comparison possible. Historical dividends, when charted graphically, can reveal the long-term variability and/or growth within the BMY dividend history record. Also see the BMY stock dividend history data table along the right-hand column below.
|
|
|
|
Hold (2.35 out of 4)
7th percentile
|
PARTNER NEWS:Fri, May 3, 3:08 AM, Zacks
The Zacks Analyst Blog Highlights Gilead Sciences, GSK, Deciphera, Bristol Myers and Editas Medicine Gilead Sciences, GSK, Deciphera, Bristol Myers and Editas Medicine are included in this Analyst Blog.
Thu, May 2, 8:02 AM, Zacks
Biotech Stock Roundup: GILD's GSK' Q1 Earnings, DCPH Soars on Acquisition News & More Deciphera Pharmaceuticals, Inc. (DCPH) and GSK are in focus on acquisition news and Q1 earnings, respectively.
|
|